Following a public comment period, the Commission has approved a final consent order, without modifications, and a letter to the commenter of record in the matter concerning Immunex Corporation and Amgen Inc. The vote to approve the final order and response to the commenter was 5-0. (FTC File No. 021-0059; staff contact is Elizabeth A. Jex, Bureau of Competition, 202-326-3273; see press release dated July 12.)
Copies of the documents mentioned in this release are available from the FTC’s Web site at http://www.ftc.gov and also from the FTC’s Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, D.C. 20580. Call toll-free: 1-877-FTC-HELP.